Next Generation Antidepressants

Moving Beyond Monoamines to Discover Novel Treatment Strategies for Mood Disorders

Nonfiction, Health & Well Being, Medical, Specialties, Psychiatry, Ailments & Diseases, Mental Health
Cover of the book Next Generation Antidepressants by , Cambridge University Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781139833448
Publisher: Cambridge University Press Publication: May 20, 2010
Imprint: Cambridge University Press Language: English
Author:
ISBN: 9781139833448
Publisher: Cambridge University Press
Publication: May 20, 2010
Imprint: Cambridge University Press
Language: English

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This 2010 book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

More books from Cambridge University Press

Cover of the book The Life of Hersch Lauterpacht by
Cover of the book Extreme Natural Hazards, Disaster Risks and Societal Implications by
Cover of the book Cosmogenic Nuclides by
Cover of the book Neurogenetics by
Cover of the book Primate Communication by
Cover of the book Appropriating the Past by
Cover of the book Language Evolution by
Cover of the book Speech and Silence in American Law by
Cover of the book Vietnam's Lost Revolution by
Cover of the book Modern Compiler Implementation in Java by
Cover of the book The Neotoma Paleoecology Database by
Cover of the book Bandung, Global History, and International Law by
Cover of the book Constitutional Dialogue by
Cover of the book Bills of Rights in the Common Law by
Cover of the book A History of Greek Philosophy: Volume 1, The Earlier Presocratics and the Pythagoreans by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy